Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citicoline for Methamphetamine Dependence
NCT00950352Phase 3Completed
- Start
- Jan 2010
- Primary completion
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in methamphetamine use disorder (MUD) comparing Citicoline with Placebo (2 arms). Primary endpoint: Methamphetamine Dependent Subjects Treated With Citicoline vs Placebo at 8 weeks. Started Jan 2010; status: completed.
02
Drugs
citicoline
03
Conditions
methamphetamine use disorder (MUD)
Beyond the preview
Go deeper on NCT00950352.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00950352.